Regulation of gene expression by estrogen in mammary gland of wild type and estrogen receptor alpha knockout mice

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 1-2, 2009, Pages 116-126

  Aboghe, David Hyacinthe ^a   Yoshioka, Mayumi ^a   Phaneuf, Daniel ^a   St Amand, Jonny ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Estradiol; Gene expression; Knockout mice; Mammary gland

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; PROTEASE NEXIN 5; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GLYCOLYSIS; GONADECTOMY; MAMMARY GLAND; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; UNINDEXED SEQUENCE; UPREGULATION; WILD TYPE;

ANIMALS; BASE SEQUENCE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 60149095586     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.12.002     Document Type: Article

References (63)

1. Gennari L., Merlotti D., De Paola V., Calabro A., Becherini L., Martini G., and Nuti R. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am. J. Epidemiol. 161 4 (2005) 307-320
2. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J., and Nilsson S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol. 54 1 (1998) 105-112
3. Bjornstrom L., and Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19 4 (2005) 833-842
4. Leygue E., Dotzlaw H., Watson P.H., and Murphy L.C. Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res. 58 15 (1998) 3197-3201
5. Clarke R.B., Howell A., Potten C.S., and Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57 22 (1997) 4987-4991
6. Liu M.M., Albanese C., Anderson C.M., Hilty K., Webb P., Uht R.M., Price Jr. R.H., Pestell R.G., and Kushner P.J. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J. Biol. Chem. 277 27 (2002) 24353-24360
7. Velculescu V.E., Zhang L., Vogelstein B., and Kinzler K.W. Serial analysis of gene expression. Science 270 5235 (1995) 484-487
8. Yoshioka M., Boivin A., Ye P., Labrie F., and St-Amand J. Effects of dihydrotestosterone on skeletal muscle transcriptome in mice measured by serial analysis of gene expression. J. Mol. Endocrinol. 36 2 (2006) 247-259
9. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., and Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127 19 (2000) 4277-4291
10. St-Amand J., Okamura K., Matsumoto K., Shimizu S., and Sogawa Y. Characterization of control and immobilized skeletal muscle: an overview from genetic engineering. Faseb J. 15 3 (2001) 684-692
11. Dinel S., Bolduc C., Belleau P., Boivin A., Yoshioka M., Calvo E., Piedboeuf B., Snyder E.E., Labrie F., and St-Amand J. Reproducibility, bioinformatic analysis and power of the SAGE method to evaluate changes in transcriptome. Nucleic Acids Res. 33 3 (2005) e26, 21-28
12. Adams M.D., Kerlavage A.R., Fleischmann R.D., Fuldner R.A., Bult C.J., Lee N.H., Kirkness E.F., Weinstock K.G., Gocayne J.D., White O., et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 377 6547 Suppl. (1995) 3-174
13. Lash A.E., Tolstoshev C.M., Wagner L., Schuler G.D., Strausberg R.L., Riggins G.J., and Altschul S.F. SAGEmap: a public gene expression resource. Genome Res. 10 7 (2000) 1051-1060
14. Bajic V.B., Tan S.L., Chong A., Tang S., Strom A., Gustafsson J.A., Lin C.Y., and Liu E.T. Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Res. 31 13 (2003) 3605-3607
15. Halees A.S., Leyfer D., Weng Z., and PromoSer:. A large-scale mammalian promoter and transcription start site identification service. Nucleic Acids Res. 31 13 (2003) 3554-3559
16. Tang S., Han H., and Bajic V.B. ERGDB: estrogen responsive Genes Database. Nucleic Acids Res. 32 Database issue (2004) D533-536
17. Tremblay G.B., Tremblay A., Labrie F., and Giguere V. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol. Cell. Biol. 19 3 (1999) 1919-1927
18. Merino-Trigo A., Kerr M.C., Houghton F., Lindberg A., Mitchell C., Teasdale R.D., and Gleeson P.A. Sorting nexin 5 is localized to a subdomain of the early endosomes and is recruited to the plasma membrane following EGF stimulation. J. Cell Sci. 117 Pt 26 (2004) 6413-6424
19. Forster C., Makela S., Warri A., Kietz S., Becker D., Hultenby K., Warner M., and Gustafsson J.A. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc. Natl. Acad. Sci. U.S.A. 99 24 (2002) 15578-15583
20. Cooke P.S., and Naaz A. Role of estrogens in adipocyte development and function. Exp. Biol. Med. (Maywood) 229 11 (2004) 1127-1135
21. Hu X.L., Liu X.P., Lin S.X., Deng Y.C., Liu N., Li X., and Yao L.B. NDRG2 expression and mutation in human liver and pancreatic cancers. World J. Gastroenterol. 10 23 (2004) 3518-3521
22. Singh J., Young L., Handelsman D.J., and Dong Q. Prostate epithelial expression of a novel androgen target gene. J. Androl. 23 5 (2002) 652-660
23. Porter D., Lahti-Domenici J., Keshaviah A., Bae Y.K., Argani P., Marks J., Richardson A., Cooper A., Strausberg R., Riggins G.J., Schnitt S., Gabrielson E., Gelman R., and Polyak K. Molecular markers in ductal carcinoma in situ of the breast. Mol. Cancer Res. 1 5 (2003) 362-375
24. Huang A., Ho C.S., Ponzielli R., Barsyte-Lovejoy D., Bouffet E., Picard D., Hawkins C.E., and Penn L.Z. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells. Cancer Res. 65 13 (2005) 5607-5619
25. Ou X.M., Chen K., and Shih J.C. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 103 29 (2006) 10923-10928
26. Suh Y.H., Kim W.H., Moon C., Hong Y.H., Eun S.Y., Lim J.H., Choi J.S., Song J., and Jung M.H. Ectopic expression of neuronatin potentiates adipogenesis through enhanced phosphorylation of cAMP-response element-binding protein in 3T3-L1 cells. Biochem. Biophys. Res. Commun. 337 2 (2005) 481-489
27. Becker M., Sommer A., Kratzschmar J.R., Seidel H., Pohlenz H.D., and Fichtner I. Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM. Mol. Cancer Ther. 4 1 (2005) 151-168
28. + pump alpha2 subunits to specialized plasma membrane microdomains. J. Biol. Chem. 281 18 (2006) 12929-12940
29. Pozzan T., Rizzuto R., Volpe P., and Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol. Rev. 74 3 (1994) 595-636
30. Ramaekers F.C., and Bosman F.T. The cytoskeleton and disease. J. Pathol. 204 4 (2004) 351-354
31. Reichelt J., Furstenberger G., and Magin T.M. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. J. Invest. Dermatol. 123 5 (2004) 973-981
32. Steinert P.M., Parry D.A., and Marekov L.N. Trichohyalin mechanically strengthens the hair follicle: multiple cross-bridging roles in the inner root shealth. J. Biol. Chem. 278 42 (2003) 41409-41419
33. Helfand B.T., Chang L., and Goldman R.D. Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell Sci. 117 Pt 2 (2004) 133-141
34. Bharadwaj S., Thanawala R., Bon G., Falcioni R., and Prasad G.L. Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene 24 56 (2005) 8291-8303
35. Lewis J.S., Vijayanathan V., Thomas T.J., Pestell R.G., Albanese C., Gallo M.A., and Thomas T. Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2. Oncol. Res. 15 3 (2005) 113-128
36. Tomlinson V.A., Newbery H.J., Wray N.R., Jackson J., Larionov A., Miller W.R., Dixon J.M., and Abbott C.M. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. BMC Cancer 5 (2005) 113
37. Shiina N., Gotoh Y., Kubomura N., Iwamatsu A., and Nishida E. Microtubule severing by elongation factor 1 alpha. Science 266 5183 (1994) 282-285
38. Bibb M.J., Van Etten R.A., Wright C.T., Walberg M.W., and Clayton D.A. Sequence and gene organization of mouse mitochondrial DNA. Cell 26 2 Pt 2 (1981) 167-180
39. Denis M.G., Chadeneau C., Lecabellec M.T., LeMoullac B., LeMevel B., Meflah K., and Lustenberger P. Over-expression of the S13 ribosomal protein in actively growing cells. Int. J. Cancer 55 2 (1993) 275-280
40. Kwong J., Xuan J.W., Chan P.S., Ho S.M., and Chan F.L. A comparative study of hormonal regulation of three secretory proteins (prostatic secretory protein-PSP94, probasin, and seminal vesicle secretion II) in rat lateral prostate. Endocrinology 141 12 (2000) 4543-4551
41. Homma H., Kurachi H., Nishio Y., Takeda T., Yamamoto T., Adachi K., Morishige K., Ohmichi M., Matsuzawa Y., and Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J. Biol. Chem. 275 15 (2000) 11404-11411
42. Bolduc C., Larose M., Yoshioka M., Ye P., Belleau P., Labrie C., Morissette J., Raymond V., Labrie F., and St-Amand J. Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J. Mol. Endocrinol. 33 2 (2004) 429-444
43. Weech P.K., Provost P., Tremblay N.M., Camato R.N., Milne R.W., Marcel Y.L., and Rassart E. Apolipoprotein D-an atypical apolipoprotein. Prog. Lipid Res. 30 2-3 (1991) 259-266
44. Zhou J., Ng S., Adesanya-Famuiya O., Anderson K., and Bondy C.A. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. Faseb J. 14 12 (2000) 1725-1730
45. Ikeda K., Emoto N., Matsuo M., and Yokoyama M. Molecular identification and characterization of a novel nuclear protein whose expression is up-regulated in insulin-resistant animals. J. Biol. Chem. 278 6 (2003) 3514-3520
46. Mahajan V.B., Pai K.S., Lau A., and Cunningham D.D. Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. Proc. Natl. Acad. Sci. U.S.A. 97 22 (2000) 12062-12067
47. Ridd K., Zhang S.D., Edwards R.E., Davies R., Greaves P., Wolfreys A., Smith A.G., and Gant T.W. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. Carcinogenesis 27 8 (2006) 1556-1566
48. Grimaldi C.M., Cleary J., Dagtas A.S., Moussai D., and Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 109 12 (2002) 1625-1633
49. Sritunyalucksana K., Wongsuebsantati K., Johansson M.W., and Soderhall K. Peroxinectin, a cell adhesive protein associated with the proPO system from the black tiger shrimp, Penaeus monodon. Dev. Comp. Immunol. 25 5-6 (2001) 353-363
50. Geserick P., Kaiser F., Klemm U., Kaufmann S.H., and Zerrahn J. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Int. Immunol. 16 10 (2004) 1535-1548
51. Berko D., Carmi Y., Cafri G., Ben-Zaken S., Sheikhet H.M., Tzehoval E., Eisenbach L., Margalit A., and Gross G. Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules. J. Immunol. 174 4 (2005) 2116-2123
52. Kim Y.U., Carroll M.C., Isenman D.E., Nonaka M., Pramoonjago P., Takeda J., Inoue K., and Kinoshita T. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation. J. Biol. Chem. 267 6 (1992) 4171-4176
53. Kobayashi K., Ogata H., Morikawa M., Iijima S., Harada N., Yoshida T., Brown W.R., Inoue N., Hamada Y., Ishii H., Watanabe M., and Hibi T. Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids. Gut 51 2 (2002) 169-176
54. Nakamura A., Mori Y., Hagiwara K., Suzuki T., Sakakibara T., Kikuchi T., Igarashi T., Ebina M., Abe T., Miyazaki J., Takai T., and Nukiwa T. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J. Exp. Med. 197 5 (2003) 669-674
55. Matsuuchi L., Gold M.R., Travis A., Grosschedl R., DeFranco A.L., and Kelly R.B. The membrane IgM-associated proteins MB-1 and Ig-beta are sufficient to promote surface expression of a partially functional B-cell antigen receptor in a nonlymphoid cell line. Proc. Natl. Acad. Sci. U.S.A. 89 8 (1992) 3404-3408
56. Manitz M.P., Horst B., Seeliger S., Strey A., Skryabin B.V., Gunzer M., Frings W., Schonlau F., Roth J., Sorg C., and Nacken W. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell. Biol. 23 3 (2003) 1034-1043
57. Lacroix M., Toillon R.A., and Leclercq G. Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. Endocr. Relat. Cancer 11 3 (2004) 497-522
58. do Nascimento C.O., Hunter L., and Trayhurn P. Regulation of haptoglobin gene expression in 3T3-L1 adipocytes by cytokines, catecholamines, and PPARgamma. Biochem. Biophys. Res. Commun. 313 3 (2004) 702-708
59. Ohsawa I., Nishimaki K., Yasuda C., Kamino K., and Ohta S. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J. Neurochem. 84 5 (2003) 1110-1117
60. Clark S.J., and Melki J. DNA methylation and gene silencing in cancer: which is the guilty party?. Oncogene 21 35 (2002) 5380-5387
61. Sotiropoulou G., Anisowicz A., and Sager R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J. Biol. Chem. 272 2 (1997) 903-910
62. Rickles F.R., Shoji M., and Abe K. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int. J. Hematol. 73 2 (2001) 145-150
63. Naaz A., Zakroczymski M., Heine P., Taylor J., Saunders P., Lubahn D., and Cooke P.S. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res. 34 11-12 (2002) 758-763